KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Total Current Liabilities (2016 - 2025)

Biogen has reported Total Current Liabilities over the past 17 years, most recently at $3.3 billion for Q4 2025.

  • Quarterly results put Total Current Liabilities at $3.3 billion for Q4 2025, down 39.42% from a year ago — trailing twelve months through Dec 2025 was $3.3 billion (down 39.42% YoY), and the annual figure for FY2025 was $3.3 billion, down 39.42%.
  • Total Current Liabilities for Q4 2025 was $3.3 billion at Biogen, up from $3.3 billion in the prior quarter.
  • Over the last five years, Total Current Liabilities for BIIB hit a ceiling of $5.5 billion in Q4 2024 and a floor of $3.0 billion in Q1 2023.
  • Median Total Current Liabilities over the past 5 years was $3.4 billion (2023), compared with a mean of $3.9 billion.
  • Peak annual rise in Total Current Liabilities hit 64.37% in 2025, while the deepest fall reached 39.42% in 2025.
  • Biogen's Total Current Liabilities stood at $4.3 billion in 2021, then fell by 23.86% to $3.3 billion in 2022, then rose by 4.93% to $3.4 billion in 2023, then surged by 60.99% to $5.5 billion in 2024, then tumbled by 39.42% to $3.3 billion in 2025.
  • The last three reported values for Total Current Liabilities were $3.3 billion (Q4 2025), $3.3 billion (Q3 2025), and $3.2 billion (Q2 2025) per Business Quant data.